{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:47:29Z","timestamp":1790801249985,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/27198-8"],"award-info":[{"award-number":["2014\/27198-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.cca.2022.07.012","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T21:36:21Z","timestamp":1658352981000},"page":"156-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Functional characterization of novel variants found in patients with suspected Fabry disease"],"prefix":"10.1016","volume":"534","author":[{"given":"Patr\u00edcia","family":"Varela-Calais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila","family":"Nicolicht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan","family":"Paulo Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia","family":"D'Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Bosco","family":"Pesquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2022.07.012_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cca.2010.07.038","article-title":"How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?","volume":"411","author":"Auray-Blais","year":"2010","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.cca.2022.07.012_b0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cca.2012.09.026","article-title":"LC-MS\/MS analysis of plasma lyso-Gb3 in Fabry disease","volume":"414","author":"Boutin","year":"2012","journal-title":"Clin. Chim. Acta."},{"issue":"5","key":"10.1016\/j.cca.2022.07.012_b0015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/jimd.12228","article-title":"Developments in the treatment of Fabry disease","volume":"43","author":"van der Veen","year":"2020","journal-title":"J. Inherit Metab. Dis."},{"key":"10.1016\/j.cca.2022.07.012_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2326409816685735","article-title":"The Challenge of Diagnosis and Indication for Treatment in Fabry Disease","volume":"5","author":"Curiati","year":"2017","journal-title":"J. Inborn Errors Metabolism Screening"},{"issue":"12","key":"10.1016\/j.cca.2022.07.012_b0025","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/gim.2016.55","article-title":"Is it Fabry disease?","volume":"18","author":"Schiffmann","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.cca.2022.07.012_b0030","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.ijcard.2012.06.069","article-title":"Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy","volume":"167","author":"Terryn","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2022.07.012_b0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.gene.2017.10.064","article-title":"Female Fabry disease patients and X-chromosome inactivation","volume":"641","author":"Juchniewicz","year":"2018","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.cca.2022.07.012_b0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/gm13","article-title":"The Human Gene Mutation Database: 2008 update","volume":"1","author":"Stenson","year":"2009","journal-title":"Genome Med."},{"key":"10.1016\/j.cca.2022.07.012_b0045","first-page":"77","article-title":"GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry\u2019s Disease?","volume":"113","author":"Chaves-Markman","year":"2019","journal-title":"Arq Bras Cardiol."},{"key":"10.1016\/j.cca.2022.07.012_b0050","doi-asserted-by":"crossref","first-page":"10:783","DOI":"10.3389\/fgene.2019.00783","article-title":"Novel GLA Mutation Promotes Intron Inclusion Leading to Fabry Disease","volume":"10","author":"Varela","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.cca.2022.07.012_b0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000503998","article-title":"Functional Characterization and Pharmacological Evaluation of a Novel GLA Missense Mutation Found in a Severely Affected Fabry Disease Family","volume":"144","author":"Varela","year":"2020","journal-title":"Nephron."},{"key":"10.1016\/j.cca.2022.07.012_b0060","doi-asserted-by":"crossref","first-page":"(1):30","DOI":"10.1186\/s13023-019-1274-3","article-title":"Correlation between GLA variants and alpha-Galactosidase A profile in dried blood spot: an observational study in Brazilian patients","volume":"15","author":"Varela","year":"2020","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.cca.2022.07.012_b0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"5","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.cca.2022.07.012_b0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11011-020-00640-0","article-title":"Fabry disease: GLA deletion alters a canonical splice site in a family with neuropsychiatric manifestations","volume":"36","author":"Varela","year":"2021","journal-title":"Metab Brain Dis."},{"key":"10.1016\/j.cca.2022.07.012_b0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2014.06.029","article-title":"Fabry's disease","volume":"344","author":"El-Abassi","year":"2014","journal-title":"J. Neurol Sci."},{"key":"10.1016\/j.cca.2022.07.012_b0080","doi-asserted-by":"crossref","unstructured":"IshiiS. Pharmacological chaperone therapy forFabrydisease. Proc Jpn Acad Ser B Phys Biol Sci.88 (2012) 18-30. Pubmed PMID: 22241068.","DOI":"10.2183\/pjab.88.18"},{"key":"10.1016\/j.cca.2022.07.012_b0085","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/postgradmedj-2018-136056","article-title":"Hot topics in Fabry disease","volume":"94","author":"Cairns","year":"2018","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.cca.2022.07.012_b0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/jhg.2012.32","article-title":"New mutations in the GLA gene in Brazilian families with Fabry disease","volume":"57","author":"Tura\u00e7a","year":"2012","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.cca.2022.07.012_b0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/humu.22910","article-title":"Functional and Clinical Consequences of Novel \u03b1-Galactosidase A Mutations in Fabry Disease","volume":"37","author":"Lukas","year":"2016","journal-title":"Hum Mutat."},{"key":"10.1016\/j.cca.2022.07.012_b0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2018.02.021","article-title":"Functional and pharmacological evaluation of novel GLA variants in Fabry disease identifies six (two de novo) causative mutations and two amenable variants to the chaperone DGJ","volume":"481","author":"Ferri","year":"2018","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.cca.2022.07.012_b0105","doi-asserted-by":"crossref","unstructured":"Garman, S.C. Garboczi, D.N. The molecular defect leading to Fabry Disease: Structure of human a-Galactosidase. J Mol Biol.337 (2004) 319-35. Pubmed PMID: 15003450.","DOI":"10.1016\/j.jmb.2004.01.035"},{"key":"10.1016\/j.cca.2022.07.012_b0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2215\/CJN.04120417","article-title":"Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome","volume":"13","author":"Warejko","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.cca.2022.07.012_b0115","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.clinbiochem.2014.02.014","article-title":"Fabry disease: a new approach for the screening of females in high-risk groups","volume":"47","author":"Pasqualim","year":"2014","journal-title":"Clin Biochem."},{"key":"10.1016\/j.cca.2022.07.012_b0120","doi-asserted-by":"crossref","unstructured":"Ferreira, S. Ortiz, A., Germain, D.P. Viana-Baptista, M. Gomes, A.C. Camprecios, M. Fenollar-Cort\u00e9s, M. Gallegos-Villalobos, A. Garcia, D. Garc\u00eda-Robles, J.A. Egido, J. Guti\u00e9rrez-Rivas, E. Herrero, J.A. Mas, S. Oancea, R. P\u00e9res, P. Salazar-Mart\u00edn, L.M. Solera-Garcia, J. Alves, H. Garman, S.C. Oliveira, J.P. The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies. 114 (2015) 248\u2013258. 10.1016\/j.ymgme.2014.11.004.","DOI":"10.1016\/j.ymgme.2014.11.004"},{"issue":"11","key":"10.1016\/j.cca.2022.07.012_b0125","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","article-title":"VarSome: the human genomic variant search engine","volume":"35","author":"Kopanos","year":"2019","journal-title":"Bioinformatics"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122012438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122012438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:06:29Z","timestamp":1757862389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898122012438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":25,"alternative-id":["S0009898122012438"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2022.07.012","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional characterization of novel variants found in patients with suspected Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2022.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}